
Treatment Patterns, Adverse Events, and Clinical Outcomes with Steroidal Mineralocorticoid Receptor Antagonists: A ...
Introduction Steroidal mineralocorticoid receptor antagonists (sMRAs), including spironolactone and eplerenone, are a class of medications primarily approved for managing various cardiovascular (CV) and endocrine conditions.1–3 Spironolactone was the first …